Structures by: Bhat S. A.
Total: 15
2-(diphenylphosphanyl)-1-{[2-(diphenylphosphanyl)-1H-imidazole]methyl}-1H-imidazole
C31H26N4P2
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=8.9713(7)Å b=10.3845(8)Å c=27.663(2)Å
α=90.00° β=90.00° γ=90.00°
5-(Diphenylphosphanyl)-1-{[5-(diphosphanyl)-1H-pyrazol-1-yl]methyl}-1H-pyrazole chloroform solvate
C31H26N4P2,CHCl3
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=12.323(2)Å b=12.892(2)Å c=12.951(2)Å
α=93.945(2)° β=117.423(2)° γ=117.267(2)°
C47H50N4P2Rh2,2(BF4)
C47H50N4P2Rh2,2(BF4)
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=15.8580(3)Å b=11.7581(3)Å c=13.3446(3)Å
α=90° β=108.8490(6)° γ=90°
C31H26Cl2N4P2Pd
C31H26Cl2N4P2Pd
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=12.041(4)Å b=18.039(6)Å c=13.169(4)Å
α=90° β=92.438(4)° γ=90°
<i>cis</i>-Dichlorido(5-(diphenylphosphanyl)-1-{[5-diphenylphosphanyl-1H-1,2,4-triazol-1-yl]methyl}-1H-1,2,4-triazole-κ^2^<i>P,P</i>)palladium(II)
C29H24Cl2N6P2Pd
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=9.9501(3)Å b=24.6633(9)Å c=11.4922(4)Å
α=90° β=98.4310(16)° γ=90°
1-({5-[diphenyl(selenylidene)-λ^5^-phosphanyl]-1H-1,2,4-triazol-1-yl}methyl)-1H-1,2,4-triazol-5-yldiphenyl-λ^5^-phosphaneselone
C29H24N6P2Se2
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=14.321(3)Å b=11.432(2)Å c=17.924(3)Å
α=90° β=103.979(2)° γ=90°
[1-({3-diphenyl(selenylidene)-λ^5^-phosphanyl]-1H-pyrazol-1-yl}methyl)-1H-pyrazol-3-yl]diphenyl-λ^5^-phosphaselenone
C31H26N4P2Se2
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=17.6873(6)Å b=9.4183(3)Å c=18.1538(6)Å
α=90° β=109.520(1)° γ=90°
Dichlorido(2-(diphenylphosphanyl)-1-{[2-(diphenylphosphanyl)-1H-imidazole]methyl}-1H-imidazole-κ^2^<i>P,P</i>)platinum(II)
C31H26Cl2N4P2Pt
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=12.0662(8)Å b=18.1114(12)Å c=13.1999(9)Å
α=90° β=92.314(1)° γ=90°
C37H36N4P2Pd2,2(BF4),CH2Cl2
C37H36N4P2Pd2,2(BF4),CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=11.1418(5)Å b=31.8019(15)Å c=11.9253(6)Å
α=90° β=102.2500(7)° γ=90°
C36H31ClN4P2Ru
C36H31ClN4P2Ru
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=9.1612(3)Å b=12.9584(5)Å c=15.8185(3)Å
α=98.610(2)° β=92.840(2)° γ=107.317(3)°
C35H31Cl3N6P2Ru
C35H31Cl3N6P2Ru
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=9.4977(3)Å b=18.3954(4)Å c=19.9460(5)Å
α=87.8663(17)° β=79.437(2)° γ=78.663(2)°
Μ-(2-(Diphenylphosphanyl)-1-{[2-(diphenylphosphanyl)-1H-imidazole]methyl}-1H-imidazole-κ
C31H26Au2Cl2N4P2,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 40 17696-17703
a=15.155(2)Å b=17.012(3)Å c=26.119(4)Å
α=90° β=90° γ=90°
C93H78Au2ClN12P6,Cl
C93H78Au2ClN12P6,Cl
Dalton transactions (Cambridge, England : 2003) (2015) 44, 40 17696-17703
a=13.2229(3)Å b=26.6831(5)Å c=24.6194(5)Å
α=90° β=95.7770(13)° γ=90°
[1-({2-[diphenyl[selenylidene)-λ^5^-phosphanyl]-1H-imidazol-1-yl}methyl)-1H-imidazol-2-yl]diphenyl-λ^5^-phosphaselenone
C31H26N4P2Se2
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=13.078(3)Å b=13.427(3)Å c=16.699(4)Å
α=90° β=103.209(4)° γ=90°
Chlorido(η^5^-cyclopentadienyl)(2-(diphenylphosphanyl)-1-{[2-(diphenylphosphanyl)-1H-imidazol-1-yl]methyl}-1H-imidazole-κ^2^P,P)ruthenium(II)
C36H31ClN4P2Ru
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=11.0252(13)Å b=25.073(3)Å c=11.0932(13)Å
α=90° β=90.325(2)° γ=90°